WASHINGTON — The U.S. Food and Drug Administration has issued a new import alert that strengthens enforcement over obesity drug […]
FDA Strengthens Controls on Obesity Drug Ingredient Imports to Protect Patients Read More »
Delhi, India — In an urgent maneuver to protect public health, the Delhi government has announced the formation of a
A Special Committee in Delhi Battles Fake Medicines in the Pharmaceutical Supply Chain Read More »
ISLAMABAD — Pakistan’s growing cancer crisis has exposed the fragile state of its pharmaceutical supply chain, where shortages, rising prices,
In Pakistan, Cancer Patients Face Rising Drug Prices and Counterfeit Medicines Read More »
Blog Post On September 5, 2025, Reuters reported that the U.S. FDA issued an import alert on GLP-1 ingredients—a move
A Wake-Up Call from Recent U.S. Policy Moves On September 3, 2025, Global Biodefense reported on a new executive order
A Global Health Warning from WHO On August 29, 2025, the World Health Organization (WHO) issued a medical product alert
The Hidden Danger of Counterfeit Fentanyl: Why Stronger Verification Is Urgent Read More »
The global trade in counterfeit medicines is growing at an alarming pace, and the latest report published by the European
The Hidden Threat of Counterfeit Medicines: What the Latest EUIPO–OECD Report Reveals Read More »
The U.S. Food and Drug Administration (FDA) recently issued a warning about counterfeit Botox discovered in multiple states. This alarming
Counterfeit Botox Raises Alarms: Why Medicine Verification Matters More Than Ever Read More »
Counterfeit drugs are not just a distant problem—they are entering the United States and putting patients at risk. Recently, the
Fake Cialis Alert: Why Counterfeit Medicines Are a Growing Global Threat Read More »
Build Safer, More Transparent Supply Chains Traceability is no longer optional in modern pharmaceutical logistics—it’s a regulatory requirement, a patient
3 Steps to Pharma Traceability Read More »
